Parasympathomimetics
Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here.
Also Known As:
Parasympathomimetic Agents; Parasympathomimetic Drugs; Parasympathomimetic Effect; Parasympathomimetic Effects; Agents, Parasympathomimetic; Drugs, Parasympathomimetic; Effect, Parasympathomimetic; Effects, Parasympathomimetic
Networked: 48
relevant articles (3 outcomes,
5 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Angioi-Duprez, K:
1 article
(05/2022)
|
2. | Bursztejn, A C:
1 article
(05/2022)
|
3. | Gillet, P:
1 article
(05/2022)
|
4. | Patchinsky, A:
1 article
(05/2022)
|
5. | Petitpain, N:
1 article
(05/2022)
|
6. | Schmutz, J L:
1 article
(05/2022)
|
7. | Abo-Elseoud, Mohammed:
1 article
(02/2022)
|
8. | Artopoulou, Eleni:
1 article
(02/2022)
|
9. | Gerakaris, Andreas:
1 article
(02/2022)
|
10. | Koniari, Ioanna:
1 article
(02/2022)
|
Related Diseases
1. | Underactive Urinary Bladder
|
2. | Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
|
3. | Myasthenia Gravis
|
4. | Glaucoma
01/01/2013
- " Medical treatment of glaucoma includes topical beta-blockers, alpha-2 agonists, prostaglandins, parasympathomimetics and CAIs. " 03/01/2014
- " Other glaucoma medications (beta blockers, carbonic anhydrase inhibitors, parasympathomimetics, and prostaglandin analogues) are classified as category C medications with uncertain safety from the lack of human studies and reported adverse effects in animal studies. " 03/01/2011
- " Prostaglandin analogs, β-blockers, α-agonists, carbonic anhydrase inhibitors and parasympathomimetics are available in our glaucoma armamentarium and are reviewed. " 05/11/2009
- " Parasympathomimetics, adrenergic antagonists, plus eventually adrenergic agonists, are commonly used for the reduction of IOP and therefore for treatment of glaucoma. " 10/01/1989
- " Four major classes of drugs are currently used to treat glaucoma: carbonic anhydrase inhibitors, beta adrenergic blockers, parasympathomimetics, and sympathomimetics. "
|
5. | Ulcer
|
|
Related Drugs and Biologics
Related Therapies and Procedures